Monday, 18 August 2014

SOME LABORATORY PROCEDURES

UNSUITABLE SAMPLE



  • Unlabeled or incorrectly labeled samples or specimens

  • The container of stool is full

  • Sputum sample contaminated with food particles or other substances

  • Insufficient samples such as urine and blood

Actions we can take

  • Inform the ward sister to send a repeat sample

  • If the sample is insufficient, clotted, contaminated or heamolysed inform the ward sister immediately for a repeat sample and document in the repeat sample register

  • If it is an OPD patient, try to contact the patient and explain the problem to the patient

  • If the OPD sample is insufficient or unsuitable on receiving, ask for a repeat sample before registering

Patient preparation for different laboratory test

  • Fasting blood sugar
    Ask the patient to fast for 8 hours
  • Post parandial blood sugarCollect blood 2 hours from the time of taking food
  • Post glucose blood sugarPatient is ask to come after 8 hours fasting, 50grams of glucose is given orally and blood is collected after 2 hours

  • Oral Glucose Tolerance Test
    Ask the patient to fast 8 hours
    Ask the patient to bring 100 grams glucose packet and a lemon
    Patient is asked to collect a fasting urine sample and blood is collected
    Patient is given 75 grams of glucose
    Take 3 more blood sample.
    Instruct the patient to collect a urine sample with each blood sample

  • Lipid profileInstruct the patient to come for blood collection after 13 hours fasting

Urine collection for routine test

The container need not to be sterile but
should be free from detergents and other impurities.
Minimum of 10ml should be collected.
For urinary porphobilinogen urine sample should be collected in a dark bottle

Collection of stool for routine test
The container for specimen collection need not be sterile
It should be a clean, leak proof, disinfectant free, wide mouthed.
The faeces specimen should not be contaminated with urine

Instruct the patient to collect a very little amount of stool.( 1 – 2 grams )

MANTOUX TEST


Materials required1.Spirit swab
2.Dry swab
3.Tuberculin PPD ( 10TU/0.1ml ), make sure that it comes to room temperature before administering and check the expiry date.
4.Tuberculin syringe


PROCEDURE
  • The preferred site for the test is the flexor dorsal surface of the forearm about 4 inches below the elbow join
  • Clean the chosen site by using 70% alcohol or spirit and allow to dry
  • The stopper of the PPD vial is cleaned with spirit or 70% alcohol
  • 0.1ml of the Tuberculin PPD solution is drawn into the sterile tuberculin syringe fitted with a short 26 – gauge needle
  • Insert the needle-point with the bevelled side upwards so that the needle opening is visible
  • Stretch the skin between finger and thumb
  • Hold the needle almost parallel to the skin
  • PPD is injected intradermally by inserting the tip of the needle into the most superficial layers of the skin with needle bevel pointing upwards
  • As the solution is injected a pale white bleb, 6 – 10 mm in diameter will rise at the needle point

NOTE
  • If significant part of the dose leaks from the injection site, the result should be repeated immediately at another site, 5 cms away from the first site
  • Instruct the patient not to scratch the area and not to apply any lotion or cosmetics
  • Instruct the patient to come to the laboratory for result of the Mantoux test which should be read at 40 – 72 hours after the injection
BLOOD TYPE
If an individual is exposed to a blood group antigen that is not recognized as self, the immune system will produce antibodies that can specifically bind to that particular blood group antigen, and an immunological memory against that antigen is formed. The individual will have become sensitized to that blood group antigen. These antibodies can bind to antigens on the surface of transfused red blood cells (or other tissue cells), often leading to destruction of the cells by recruitment of other components of the immune system.When IgM antibodies bind to the transfused cells, the transfused cells can clump. It is vital that compatible blood is selected for transfusions and that compatible tissue is selected for organ transplantation. Transfusion reactions involving minor antigens or weak antibodies may lead to minor problems. However, more serious incompatibilities can lead to a more vigorous immune response with massive RBC destruction, low blood pressure, and even death.A blood type (also called a blood group) is a classification of blood based on the presence or absence of inherited antigenic substances on the surface of red blood cells (RBCs). These antigens may be proteins, carbohydrates, glycoproteins, or glycolipids, depending on the blood group system, and some of these antigens are also present on the surface of other types of cells of various tissues. Several of these red blood cell surface antigens that stem from one allele (or very closely linked genes), collectively form a blood group system.Blood types are inherited and represent contributions from both parents. A total of 30 human blood group systems are now recognized by the International Society of Blood Transfusion (ISBT). Many pregnant women carry a fetus with a different blood type from their own, and the mother can form antibodies against fetal RBCs. Sometimes these maternal antibodies are IgG, a small immunoglobulin, which can cross the placenta and cause hemolysis of fetal RBCs, which in turn can lead to hemolytic disease of the newborn, an illness of low fetal blood counts which ranges from mild to severe.
Anisocytosis with hypochromia and microcytes (IDA)

Iron-deficiency anemia (IDA) is the most commonly encountered anemia and may be due to [1] impaired iron intake, [2] pregnancy, [3] intravascular hemolysis, [4] hemorrhage, or [5] lactation. IDA most often affects women in their reproductive years and growing children. Each mL of packed RBC’s contain about 1.0 mg of iron. The average adult contains about 3.5 to 5.0 grams of iron. They will ingest about 15 to 20 mg of iron daily, excreting most of it. The body normally absorbs about 1 mg of iron (which is equal to the daily loss).
The iron taken into the body is in the ferric state (Fe+3) in the stomach, it is changed to the ferrous state (Fe+2). Ferrous iron is absorbed by the small intestine and in the intestinal capillary system, iron is bound to transferrin to form a protein-iron complex. This complex is carried to the bone marrow (and other cells requiring iron) and will bind to the cell. The complex is absorbed into the cell, the iron released, and the transferrin moves back into the blood stream. Inside the cell, the iron is bound to the protein apoferritin to form ferritin. The ferritin combines to form aggregates which forms brown pigment granules called hemosiderin. IDA is a hypoproliferative, microcytic, hypochromic anemia due to ineffective RBC and/or hemoglobin production.
If IDA is observed in a healthy appearing adult male, the physician should look for a gastrointestinal lesion that may be losing blood. The menstruating woman will lose between 50 and 70 mLs of blood monthly and when the iron is not being replace anemia will result. It is estimated that up to 20% of the women in the US have IDA. IDA produces a hypochromic, microcytic anemia. On the peripheral blood smear, the erythrocytes are hypochromic and microcytic. If IDA is severe, poikilo-cytosis and anisocytosis may be obvious. In the bone marrow, the rubriblasts will be poorly hemoglobinized and demonstrate ragged appearing cytoplasm. The serum iron will be decreases and the total iron binding capacity (TIBC) will be increased. The ferritin level will be less than 20 ng/mL.
IRON TRIVIA
If dietary iron is from meat sources, it is heme bound. Vitamin C is not required for absorption. If this iron is from eggs and vegetables, it is in the ferritin and hemochrome bound form and requires vitamin C for optimum absorption. In the stomach, the gastric fluid and pepsin releases iron which passes into the gastrointestinal tract. Most iron absorption occurs in the duodenum. Some iron absorption will occur in the jejunum and ileum.
In developed countries, adequate ion intake is not a problem. The high risk groups who are most likely to develop IDA are [1] infants, [2] rapidly growing adolescents, [3] pregnant women, and [4] women during their child bearing years (losing from 10 to 45 mg/month). The pregnant female need about 3.4 mg of iron daily (a total of 1000 mg to carry the fetus to term). About 400 mg are needed for the fetal RBC mass. At parturition, approximately 300 mg will be lost and up to 170 mg will be contained in the placenta and umbilical cord.
It has been estimated that a healthy adult male would require about eight years to develop IDA if no more iron were absorbed in his diet. Malabsorption is uncommon unless there is a primary problem as [1] sprue, [2] gastrectomy, or [3] atrophic gastritis. Other causes are [1] regular blood donations and [2] paroxysmal nocturnal hemoglobinuria.
CLINICAL SYMPTOMSEarly stages (stage 1) are generally asymptomatic. As IDA develops into stage two, the depletion of the body’s iron stores occurs, with the patient experiencing hypoxia, characterized by lethargy and asthenia. As stage two progresses, iron deficiency is demonstrated by a decrease in erythropoiesis as iron is no longer being inserted into the hemoglobin molecule. Lab testing will show decreases in serum iron, increased total iron binding capacity (TIBC), and low transferrin saturation.
As the IDA progresses into the stage three level, the mitotic activity of the RBC increases resulting in small erythrocytes (microcytes) and hypochromia. When the hypochromic microcyte is observed in the blood film, there is also anisocytosis and poikilocytosis and IDA if fully expressed. Symptoms that begin to appear in stage two and are fully expressed in stage three are [1] ankle edema, [2] exertional dyspnea, [3] headaches, [4] glossitis, [5] koilonychia, [6] pallor, [7] pica, and [8] tachycardia. In the woman of child bearing age, [1] menorrhagia, [2] irregular cycles, and/or [3] amenorrhea may occur.

CLINICAL LABORATORY FINDINGSRBC count: Usually normal at the beginning. The count will usually remain within normal limits unless the iron stores are severely depleted.Hemoglobin: Will undergo greater degrees of reduction.
Individual are to be considered anemic if hemoglobin values fall as indicated in g/dL:
  • [1] Children (from 6 months to 5 years) less than 11
  • 2] Children (from 6 years to 14 years) less than 12
  • Adult men. . . . . . . . . . . . . . . . . . . . . . less than 13
  • Adult women. . . . . . . . . . . . . . . . . . . less than 12
  • Pregnant women . . . . . . . . . . . . . . . . less than 11
RBC Indices: Anemia is suspected when the values fall as indicated:
  • [1] MCV . . . . . 75 to 80 fL
  • [2] MCH . . . . . 25 to 27 pG
  • MCHC. . . . less than 32 percent
  • [4] If the MCV is less than 75 fl.
  • If the MCH is less than 25 pG
Retic Count: This test parameter may be normal or decreased in early IDA. As the IDA progresses, the retic count decreases
Fragility: This test will usually be normal. If codocytes (target cells) are present, then one may see a decreased value. The value of this test is in detecting hereditary spherocytosis
WBC: The count is usually normal as is the differential
Platelet count: This testing parameter is usually normal
Serum Iron: decreases in stages as IDA develops
Normal values (μg/dL) as follows
  • Newborn . . . . . . . 100 to 250
  • Infant . . . . . . . . . 40 to 100
  • Child . . . . . . . . . 50 to 120
  • Adult male. . . . . . 65 to 170
  • Adult female . . . . 50 to 170
Serum Ferritin: Is an indicator of how much iron is being stored and it will progressively decrease as IDA develops. It is the major iron storage compound and is found in all body cells. It is a protein that is complexed with iron. If iron is absent from this protein, it is then know as apoferritin. This is an important test in differentiating IDA from other types of microcytic normocytic anemias as it will be increased in thalassemia and sideroblastic type anemias. Normal values for men are 15 to 200 μg/L and women are 12 to 150 μg/L
Generalized test findings as IDA develops:
[1] In the initial stages when patient is asymptomatic:
  • A. Serum ferritin will be decreased
  • B. Bone marrow iron will be decreased
[2] In the second stage, when erythropoiesis is occurring withoutiron to insert in the heme portion of the hemoglobin molecule:
  • A. Serum Ferritin continues to be decreased
  • B. Bone marrow iron continues to be decreased
  • C. Serum iron is now decreased
  • D. TIBC is increased
[3] In the final stage with fully developed IDA
  • A. Serum Ferritin, bone marrow iron, and serum iron are decreased
  • B. TIBC is increased
  • C. Hemoglobin and hematocrit are decreased
  • D. MCV is decreased
  • E. RDW is increased

                                                                   IMMUNE RESPONSE